The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: This study aimed to identify clinical features associated with premature mortality in a large contemporary cohort of adults with type 1 diabetes. RESEARCH DESIGN AND METHODS: The Finnish Diabetic Nephropathy (FinnDiane) study is a national multicenter prospective follow-up study of 4,201 adults with type 1 diabetes from 21 university and central hospitals, 33 district hospitals, and 26 primary health care centers across Finland. RESULTS: During a median 7 years of follow-up, there were 291 deaths (7%), 3.6-fold (95% CI 3.2–4.0) more than that observed in the age- and sex-matched general population. Excess mortality was only observed in individuals with chronic kidney disease. Individuals with normoalbuminuria showed no excess mortality beyond the general population (standardized mortality ratio [SMR] 0.8, 95% CI 0.5–1.1), independent of the duration of diabetes. The presence of microalbuminuria, macroalbuminuria, and end-stage kidney disease was associated with 2.8, 9.2, and 18.3 times higher SMR, respectively. The increase in mortality across each stage of albuminuria was equivalent to the risk conferred by preexisting macrovascular disease. In addition, the glomerular filtration rate was independently associated with mortality, such that individuals with impaired kidney function, as well as those demonstrating hyperfiltration, had an increased risk of death. CONCLUSIONS: An independent graded association was observed between the presence and severity of kidney disease and mortality in a large contemporary cohort of individuals with type 1 diabetes. These findings highlight the clinical and public health importance of chronic kidney disease and its prevention in the management of type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetic nephropathy, whether manifesting as microalbuminuria, macroalbuminuria, or a reduced glomerular filtration rate progressively augments the overall risk of macrovascular complications.118”
From Type 1 diabetes (2018) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, UACR is a continuous measurement, and differences within the normal and abnormal ranges are associated with kidney and cardiovascular outcomes (6,10,11).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, UACR is a continuous measurement, and differences within the normal and abnormal ranges are associated with kidney and cardiovascular outcomes (6,11,12).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885 · cited 3×
“9* Any retinopathy 76 (29)† 1,313 (50) 420 (93)† 290 (99)† Retinopathy requiring laser therapy 27 (10)† 683 (25) 360 (78)† 288 (97)† Current smoker 98 (37)† 614 (24) 95 (22) 49 (16)† Established macrovascular disease 31 (11)† 123 (5) 116 (25)† 138 (47)† Macroalbuminuria 2 (3)† 210 (8) 338 (73)† N/A Microalbuminuria 2…”
MethodIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
Albuminuria reflects widespread vascular damage: The Steno hypothesis
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989) · Diabetologia · doi:10.1007/bf00285287 · Cited by 1,400
Doqi, K. (2002) · American Journal of Kidney Diseases · Cited by 1,285
Global guideline for type 2 diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.001 · Cited by 1,064
Conditioning Diagnostics: Collinearity and Weak Data in Regression
Goldstein, R. (1993) · Technometrics · doi:10.1080/00401706.1993.10484997 · Cited by 911
(2004) · doi:10.1177/0049124103262065 · Cited by 906
Cited by
Items 401–500 of 651
Sandholm, N., Valo, E., Tuomilehto, J., Harjutsalo, V., Groop, P., Koivula, S., Uggeldahl, T., Forslund, T., Halonen, A., Koistinen, A., et al. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.07.026 · Cited by 5
Self-citationJairoun, A. A., Ping, C. C., & Ibrahim, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-58574-x · Cited by 10
Ma, Y., Ji, J., Liu, X., Zheng, X., Xu, L., Zhou, Q., Li, Z., & Yang, L. (2024) · Kidney Diseases · doi:10.1159/000539689 · Cited by 8
Bulum, T., Prkačin, I., Blaslov, K., Zibar, K., & Duvnjak, L. S. (2013) · PubMed · Cited by 8
Kidney disease in diabetology: lessons from 2010
Schernthaner, G. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq837 · Cited by 8
Abdulrahim, H. A., Odetayo, A. F., Owootori, E. A., Bulus, J. D., Jimoh, F. B., Gabriel, E. O., Odiete, I. F., & Olayaki, L. A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03478-w · Cited by 9
“Also, DKD has been identified as a major contributing factor to cardiovascular dysfunction (Groop et al. 2009; Orchard et al. 2010).”
Chillarón, J. J., Roux, J. A. F., Sales, M. P., de Dou, J. P., Castells, I., Benaiges, D., & Pedro‐Botet, J. (2013) · PubMed · doi:10.3265/nefrologia.pre2012.oct.11643 · Cited by 8
“Microalbuminuria Normoalbuminuria p o proteinuria n 59 232 Sexo (V/M) 38/21 128/104 ns Edad (años ± DE) 42,0 ± 12,3 37,1 ± 11,5 0,004 Tiempo de evolución DM1 (años ± DE) 22,5 ± 11,5 14,1 ± 10,1 < 0,0001 Tabaquismo activo, n (%) Sí 23 (39,0) 87 (37,5) ns No 23 (39,0) 120 (51,7) < 0,05 Exfumadores 13 (22,0) 25 (10,8) <…”
Waasdorp, M., Duitman, J., & Spek, C. A. (2017) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2017.03.009 · Cited by 8
Li, J., Yu, S., Tan, Z., Yu, Y., Luo, L., Zhou, W., Zhu, L., Wang, T., Cao, T., Tu, J., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.706928 · Cited by 9
Genetic Determinants of Microvascular Complications in Type 1 Diabetes
Heltianu, C., Guja, C., & Mane, S.-A. (2011) · InTech eBooks · doi:10.5772/22065 · Cited by 9
“In Europe, these variations are not explained by the country T1DM incidence rate or its gross domestic product, but are greatly influenced by the presence of its chronic complications, especially diabetic renal disease (Groop et al., 2009; Patterson et al., 2007).”
Comorbidities and survival of patients with type 1 diabetes on renal replacement therapy
Helve, J., Haapio, M., Groop, P., Grönhagen‐Riska, C., & Finne, P. (2011) · Diabetologia · doi:10.1007/s00125-011-2140-6 · Cited by 8
“recent studies from Finland and the USA revealed that patients with type 1 diabetes and normoalbuminuria showed no excess mortality beyond the general population, but ESRD was associated with 18 and 30 times higher standardised mortality ratios, highlighting the importance of chronic kidney disease as the major risk f…”
BackgroundSelf-citationIbuprofen attenuates nephropathy in streptozotocin-induced diabetic rats
LIU, Y.-W., Zhu, X., Cheng, Y., Lü, Q., Zhang, F., Guo, H., & Yin, X. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5150 · Cited by 8
“Furthermore, a previous study demonstrated that in Finnish adults with type 1 diabetes, the mortality associated with diabetes was almost entirely confined to those with chronic kidney diseases (13).”
Heller, T., Kloos, C., Lehmann, T., Schiel, R., Lorkowski, S., Wolf, G., Müller, U. A., & Muller, N. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-113452 · Cited by 9
Secrest, A. M., Washington, R., & Orchard, T. J. (2018) · Europe PMC (PubMed Central) · Cited by 20
Increased Subclinical Coronary Artery Pathology in Type 2 Diabetes With Albuminuria
Rasmussen, I. K. B., Skriver-Møller, A.-C., Ripa, R. S., Hasbak, P., Wasehuus, V. S., Hadji-Turdeghal, K., Zobel, E. H., Lassen, M. L., Holmvang, L., Slomka, P. J., et al. (2023) · Diabetes · doi:10.2337/db23-0529 · Cited by 7
Long, C., Feng, H., Liu, Z., Li, Z., Liu, J., Jiang, Y., & Yue, R. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1028257 · Cited by 7
Zusi, C., Rioda, M., Maguolo, A., Emiliani, F., Unali, I., Costantini, S., Corradi, M., Contreas, G., Morandi, A., & Maffeis, C. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02128-6 · Cited by 7
Jiang, Y., Li, Z., Yue, R., Liu, G., Yang, M., Long, C., & Yan, D. (2023) · Food & Function · doi:10.1039/d3fo02407e · Cited by 7
Methylglyoxal-Derived Nucleoside Adducts Drive Vascular Dysfunction in a RAGE-Dependent Manner
Lai, S. W. T., Bhattacharya, S., Gonzalez, E. D. J. L., & Shuck, S. C. (2024) · Antioxidants · doi:10.3390/antiox13010085 · Cited by 8
Østergaard, J. A., Sigfrids, F. J., Forsblom, C. M., Dahlström, E. H., Thorn, L. M., Harjutsalo, V., Flyvbjerg, A., Thiel, S., Hansen, T. K., & Groop, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-88352-y · Cited by 8
Self-citationVigers, T., VINOVSKIS, C. L., Li, L., Prasad, P. V., Heerspink, H. J. L., D’Alessandro, A., Reisz, J. A., Piani, F., Cherney, D. Z. I., van Raalte, D. H., et al. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05531-3 · Cited by 7
Epidemiology of Type 1 Diabetes
Stene, L. C., & Tuomilehto, J. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch3 · Cited by 7
Yuan, Y., Qiu, H., Hu, X., Luo, T., Gao, X., Zhao, X.-Y., Zhang, J., Wu, Y., Qiao, S., Yang, Y., et al. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.239316 · Cited by 7
Diabetes and Long-Term Complications
Cagliero, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00051-2 · Cited by 11
(2020) · Diabetes : current and future developments · doi:10.2174/97898114220031200101 · Cited by 7
Setti, M. O., Kacimi, S. E. O., NISKANEN, L. K., & Tuomainen, T. (2021) · International Urology and Nephrology · doi:10.1007/s11255-021-03048-6 · Cited by 9
Qin, C., Wu, Y., Zou, Y., Zhao, Y., Kang, D., & Liu, F. (2025) · BMC Nephrology · doi:10.1186/s12882-025-03983-x · Cited by 6
Xu, C., Wang, J., Wang, C.-L., Wang, W., Zhang, Q.-M., Chokkakula, S., & Wang, N. (2025) · Food & medicine homology. · doi:10.26599/fmh.2026.9420112 · Cited by 6
Liew, A., Bavanandan, S., Hao, C., Lim, S. K., Prasad, N., Sahay, M., Susantitaphong, P., Roberts, V., Wijewickrama, E. S., Wong, M. G., et al. (2025) · Nephrology · doi:10.1111/nep.70030 · Cited by 7
Diabetic Kidney Disease: Much Progress, But Still More to Do
Molitch, M. E. (2015) · Diabetes Spectrum · doi:10.2337/diaspect.28.3.154 · Cited by 6
Dietary intake in type 1 diabetes at different stages of diabetic kidney disease
Ahola, A. J., Forsblom, C. M., Harjutsalo, V., & Groop, P. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.06.016 · Cited by 6
Self-citationGiurgea, G., Nagl, K., Gschwandtner, M. E., Höbaus, C., Hörtenhuber, T., Koppensteiner, R., Margeta, C., Fritsch, M., Rami-Merhar, B. M., Schernthaner, G.-H., et al. (2014) · Wiener klinische Wochenschrift · doi:10.1007/s00508-014-0640-3 · Cited by 6
Camoin, M., Velho, G., Saulnier, P., Potier, L., Abouleka, Y., Carpentier, C., Dubois, S. G., Larroumet, A., Rigalleau, V., Gand, E., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01487-8 · Cited by 7
“Finally, 41% of participants in our cohorts had a baseline history of DKD, which has been recognized as a major predictor of death in patients with type 1 diabetes [30].”
BackgroundEpidemiology of Type 1 Diabetes
Stene, L. C., & Tuomilehto, J. O. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch4 · Cited by 10
Onda, Y., Nishimura, R., Morimoto, A., Sano, H., Utsunomiya, K., & Tajima, N. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.05.014 · Cited by 6
“However, other studies have demonstrated a 13-fold increased risk of death in type 1 diabetic patients with ESRD compared to those without (Finne, Reunanen, Stenman, Groop, & Gronhagen-Riska, 2005), and nephropathy is still a significant prognostic factor in type 1 diabetes (Groop et al., 2009; Jorgensen et al., 2013).”
BackgroundRenal Disease in Diabetes Mellitus: Recent Studies and Potential Therapies
Iqbal, S. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s9-006 · Cited by 7
“The Finnish Diabetic Nephropathy study showed that in 4201 type 1 DM adults followed over a median of 7 years, those who were normoalbuminuric had a similar mortality risk as the general population [30].”
BackgroundChai, S., Wu, S., Xin, S., Yuan, N., Sun, J., Zhang, X., & Ji, L. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001914 · Cited by 6
Norwegian Childhood Diabetes Registry: Childhood onset diabetes in Norway 1973-2012
Skrivarhaug, T. (2013) · Norsk Epidemiologi · doi:10.5324/nje.v23i1.1598 · Cited by 6
Bulum, T., Kolarić, B., Prkačin, I., & Duvnjak, L. S. (2013) · PubMed · Cited by 6
Is Treatment of Nephropathy in Type 1 Diabetes Efficacious but Ineffective?
Nelson, R. G. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010076 · Cited by 6
Rimpeläinen, K., Sigfrids, F. J., Gordin, D., Klemetti, M., Harjutsalo, V., Groop, P., & Thorn, L. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02804-7 · Cited by 3
Self-citationPopovic, D. S., Koufakis, T., Patoulias, D., & Παπάνας, Ν. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2274988 · Cited by 5
“The leading primary cause of death in all groups of T1DM individuals with CKD was cardiovascular disease (CVD) [3].”
BackgroundResultInfluentialStem Cells Reprogramming in Diabetes Mellitus and Diabetic Complications: Recent Advances
Madkor, H. R., El‐Aziz, M. K. A., El‐Maksoud, M. S. A., Ibrahim, I. M., & Ali, F. E. M. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998275428231210055650 · Cited by 6
Luo, H., Yang, L., Ma, D., Bao, X., Zhang, G., Li, B., Cao, S., Liu, S., Bao, L., Jing, E., et al. (2024) · Molecular Immunology · doi:10.1016/j.molimm.2024.01.003 · Cited by 5
An Update on Diabetic Renal Disease
Walker, J. D. (2010) · The British Journal of Diabetes · doi:10.1177/1474651410371953 · Cited by 5
Managing Cardiovascular Complications in Diabetes
Betteridge, J. D., & Nicholls, S. J. (2014) · Wiley eBooks · doi:10.1002/9781118337967 · Cited by 6
Genetics of Diabetes and Diabetic Complications
Prasad, R. B., Ahlqvist, E., & Groop, L. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_6 · Cited by 6
Type 1 Diabetes and Cardiovascular Health
Pesantez, M., Ebekozien, O. A., & Vendrame, F. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2023.07.003 · Cited by 5
Ali, T. M., Elesawy, B. H., & Elmorsy, E. A. (2015) · National Journal of Physiology Pharmacy and Pharmacology · doi:10.5455/njppp.2015.5.1401201522 · Cited by 6
Adherence to cardio-protective medications and cardiovascular disease in adults with type 1 diabetes
Lithovius, R., Mutter, S., Parente, E. B., Harjutsalo, V., & Groop, P. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111794 · Cited by 4
Self-citationYokoyama, A., Suzuki, S., Okamoto, K., & Sugawara, A. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0083 · Cited by 4
Fernández‐González, J. F., García‐Pedraza, J. Á., Ordóñez, J. L., Terol‐Úbeda, A. C., Martín, M. L., Morán, A., & García, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021378 · Cited by 4
“exogenous NA are higher in diabetic than in normoglycaemic animals supports both the development of diabetic peripheral neuropathy and microvascular complications in the kidney [37,38].”
BackgroundEndotrophin as a risk marker of mortality and kidney complications in a type 1 diabetes cohort
Møller, A. L., Tougaard, N. H., Rasmussen, D. G. K., Genovese, F., Rønn, P. F., Hansen, T. W., Karsdal, M. A., & Rossing, P. R. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1229579 · Cited by 4
“, 2016), and chronic kidney disease (CKD) increase the overall risk of cardiovascular complications (Groop et al., 2009).”
BackgroundInkeri, J., Harjutsalo, V., Martola, J., Putaala, J., Groop, P., Gordin, D., Thorn, L., Koivula, S., Uggeldahl, T., Forslund, T., et al. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02211-y · Cited by 3
“Medical records and in-depth questionnaires, previously described, were part of the clinical data [13].”
BackgroundSelf-citationMirea, O., Oghli, M. G., Neagoe, O., Berceanu, M. C., Țieranu, E. N., Moraru, L., Raicea, V. C., & Donoiu, I. (2025) · Diabetology · doi:10.3390/diabetology6010005 · Cited by 6
“The relationship between diabetes and kidney disease onset and progression is well established, with diabetes being the most determinant cause of kidney transplants in developed countries [22].”
İnözü, M., Büyükyılmaz, G., Avcı, B., Aygar, İ. S., Çaycı, F. Ş., Uçaktürk, S. A., Mengen, E., Özlü, S. G., & Bayrakçı, U. S. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-06278-3 · Cited by 4
“T1DM is a common chronic disease among children, and DKD is one of the most common and important microvascular complications of T1DM [1].”
New strategies to tackle diabetic kidney disease
Batu, D., & Cooper, M. E. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000234 · Cited by 5
Marcovecchio, M. L., Tossavainen, P. H., Owen, K. R., Fullah, C., Benitez‐Aguirre, P., Masi, S., Ong, K. K., Nguyen, H., Chiesa, S. T., Dalton, R. N., et al. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12515 · Cited by 4
“Risk for CVD in patients with T1D is strongly associated with the presence of renal disease, as supported by the higher CVD morbidity and mortality in people with increased albumin excretion rates [7,8].”
BackgroundCristiano, E., Miles, J. M., Worsham, S., Wiegmann, P. S., Sharma, M., Rakhra, V., Goel, A., Wiegmann, T. B., & Garcia‐Touza, M. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.07.017 · Cited by 4
IL-17A rs2275913 gene polymorphism in patients with diabetic nephropathy
Nazarian, A., Hejazian, S. M., Ahmadian, E., Vahed, S. Z., Haghi, M., Mobasseri, M., & Ardalan, M. (2022) · Immunopathologia Persa · doi:10.34172/ipp.2022.29320 · Cited by 4
Jensen, K. H., Persson, F., Hansen, D., Bressendorff, I. O., Møller, M., Rossing, P. R., Gravesen, E., Kosjerina, V., Vistisen, D., & Borg, R. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad150 · Cited by 4
“Diabetic kidney disease ( DKD ) is a severe complication of diabetes that leads to increased risk of kidney failure and cardiovascular diseases, as well as the excess mortality associated with diabetes [ 1 –5 ].”
BackgroundElmeazawy, R. Z., Shall, S. I. E., AbdElsamea, M. Z., & Emara, M. H. (2024) · Egyptian Pediatric Association Gazette · doi:10.1186/s43054-024-00290-2 · Cited by 4
“It is critical to identify those people who are more likely to die in order to assess the prognosis of any type 1 diabetic and guide preventative treatments [1].”
BackgroundThe timing of dialysis and kidney transplantation in type 1 diabetes
Pavlakis, M. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01562.x · Cited by 4
Færch, L., Sejling, A., Lajer, M., Tarnow, L., Thorsteinsson, B., & Pedersen‐Bjergaard, U. (2013) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320313494431 · Cited by 4
Ota, E., Tanaka, H., Mochizuki, Y., Yamauchi, Y., Shiraki, H., Yamashita, K., Shono, A., Suzuki, M., Sumimoto, K., Yokoi, A., et al. (2022) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-022-02613-z · Cited by 4
Horita, S., Watanabe, G., Misaka, S., Taira, S., Satoh, M., Maejima, Y., Shimomura, K., Shimabukuro, M., Kazama, J. J., & SHIGETOMI, S. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00180.2023 · Cited by 3
Type 1 Diabetes Mellitus and Dyslipidemia
Maahs, D. M., & Eckel, R. H. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_7 · Cited by 4
Albuminuria and low bone mineral density in paediatric patients with type 1 diabetes
de Souza, K. S. C., Gomes, I. D. S., Oliveira, Y. M. D. C., Loureiro, M. B., da Silva, H. P. V., de Melo, T. R., dos Santos, M. G., Bortolin, R. H., Neto, J. J. M., Arrais, R. F., et al. (2018) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.14214 · Cited by 3
Clinical and functional characteristics of arterial stiffness in elderly
Murkamilov, I. T., Aitbaev, K. A., Fomin, V. V., Абдилалимовна, М. Ж., Реджапова, Н. А., & Yusupov, F. A. (2021) · Systemic Hypertension · doi:10.26442/2075082x.2021.1.200721 · Cited by 3
THE PRO-INFLAMMATORY ROLE OF MICRORNA-29b IN DIABETIC NEPHROPATHY
Jabbar, N. K., Almzaiel, A. J., & Jabir, F. A. (2019) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2019.v12i10.34766 · Cited by 3
Catamo, E., Robino, A., Dovč, K., Tinti, D., Tamaro, G., Bonfanti, R., Franceschi, R., Rabbone, I., Battelino, T., & Tornese, G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1186913 · Cited by 3
“Despite improvements inmanagement, kidney and cardiovascular diseases are still significant causes of mortality among people with T1D (13, 14).”
BackgroundTarkkonen, A., Claesson, T.-B., Eriksson, M. I., Forsblom, C. M., Thorn, L. M., Summanen, P. A., Groop, P., Putaala, J., Gordin, D., & Martola, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1134530 · Cited by 3
Self-citationRossing, P. R., & Flyvbjerg, A. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch44 · Cited by 3
Marcovecchio, M. L., & Dunger, D. B. (2012) · Diabetes Management · doi:10.2217/dmt.12.67 · Cited by 4
Preventing kidney failure in people with diabetes
Marshall, S. M. (2014) · Diabetic Medicine · doi:10.1111/dme.12535 · Cited by 3
Lithovius, R., Harjutsalo, V., Saraheimo, M., Forsblom, C. M., Groop, P., & on behalf of the FinnDiane Study Group (2012) · Annals of Medicine · doi:10.3109/07853890.2012.671535 · Cited by 3
Self-citationParity and mortality in cases of childhood‐onset diabetes mellitus
Sjöberg, L., He, L., Kaaja, R., Tuomilehto, J., & Pitkäniemi, J. M. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2778 · Cited by 3
Levels of different adipocytokines in chronic complications of type 1 diabetes mellitus
Popovic, D. S., & Sekeruš, V. (2016) · Integrative Obesity and Diabetes · doi:10.15761/iod.1000156 · Cited by 5
“The development of CVD in absence of impairment of renal function is rarely seen in T1DM patients [8,16].”
BackgroundResultSourij, H., Edlinger, R., Prischl, F. C., Auinger, M., Kaser, S., Horn, S., Paulweber, B., Kautzky‐Willer, A., Säemann, M. D., Prager, R., et al. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-018-1425-x · Cited by 3
Effects of Usnic Acid on Hyperglycemia and Renal Function in Streptozotocin-Induced Diabetic Rats
Amin, R., Patel, S., Kumar, S., Zito, W. S., & Barletta, M. A. (2018) · Archives of Natural and Medicinal Chemistry · doi:10.29011/2577-0195.100019 · Cited by 5
Quiñones, S. D. L., Luque‐Ramírez, M., Fernández, A. C. M., Tobar, A. Q., Quiñones‐Silva, J., Martínez-García, M. Á., Insenser, M. R., Avendaño, B. D., Escobar-Morreale, H. F., & Nattero‐Chávez, L. (2025) · Metabolites · doi:10.3390/metabo15010055 · Cited by 2
Herrlin, I., Sigfrids, F. J., Sandholm, N., Thorn, L. M., Groop, P., & Harjutsalo, V. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103232 · Cited by 2
Self-citationFang, Y., Jing, L., Zhu, Y., Wang, H., Xia, J., Lei, T., Lu, J., & Gao, J. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109162 · Cited by 2
Mortality in childhood-onset type 1 diabetes: Nationwide population based data from Norway
Skrivarhaug, T. (2013) · Norsk Epidemiologi · doi:10.5324/nje.v23i1.1607 · Cited by 3
Keisala, E., Kauppala, T., Vanhamäki, S., Haapakoski, J., Laatikainen, T., & Metso, S. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2026.109312 · Cited by 2
Factors associated with resistance to complications in long-standing type 1 diabetes in China
Liu, W., Wang, Y., Han, X., Cai, X., Zhu, Y. M., Zhang, M., Gong, S., Li, J., & Ji, L. (2020) · Endocrine Connections · doi:10.1530/ec-19-0521 · Cited by 2
Cancho, B., Robles, N. R., Félix-Redondo, F. J., Lozano, L., & Fernandez-Berges, D. J. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2020.10.021 · Cited by 2
Saracyn, M., Kisiel, B. M., Franaszczyk, M., Brodowska-Kania, D. A., Żmudzki, W., Małecki, R., Niemczyk, L., Dyrla, P., Kamiński, G., Płoski, R., et al. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i10.1765 · Cited by 2
Diabetic Nephropathy in Children
Marcovecchio, M. L., & Chiarelli, F. (2015) · Springer eBooks · doi:10.1007/978-3-662-43596-0_45 · Cited by 2
Hacıoğlu, Y., Pişkinpaşa, M. E., Kılıçkaya, P., Niyazoğlu, M., Hacıoğlu, B., & Hatipoğlu, E. (2022) · Istanbul Medical Journal · doi:10.4274/imj.galenos.2022.44788 · Cited by 3
Clinical Care of Lipids in People with Type 1 Diabetes
Lan, N. S. R., Jenkins, A. J., & Fegan, P. G. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_28 · Cited by 3
Rajapaksa, R., Davis, W. A., & Davis, T. M. E. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003501 · Cited by 3
Fifteen-minute consultation: Management of albuminuria in children and young people with diabetes
Weber, I., Myles, C., Hendriks, E., Marcovecchio, M. L., & Fisher, B. G. (2023) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2023-326275 · Cited by 2
Poon, M., Chan, A. K. F., Cusumano, J. M., Craig, M. E., & Donaghue, K. C. (2024) · Pediatric Diabetes · doi:10.1155/2024/8194756 · Cited by 2
“Mortality data were obtained by linkage with the National Death Index (NDI) [20] (maintained by the Australian Institute of Health and Welfare) in February 2014, including all deaths from date of diabetes onset until the linkage date.”
BackgroundMethodOkuma, H., Tsutsumi, T., Ichijo, M., Kobayashi, T., & Tsuchiya, K. (2024) · Cureus · doi:10.7759/cureus.71055 · Cited by 2
Histology of Human Diabetic Nephropathy
Amann, K., & Daniel, C. (2012) · Wiley eBooks · doi:10.1002/9781118494073.ch5 · Cited by 2
Rathsman, B., Donner, M. G., Ursing, C., & Nyström, T. (2015) · Diabetic Medicine · doi:10.1111/dme.12897 · Cited by 2
Excess mortality in well-controlled T1DM without renal disease
Karalliedde, J. J., & Viberti, G. C. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.249 · Cited by 2
Biochemical Variables and Survival of Patients with Type 1 Diabetes on Renal Replacement Therapy
Helve, J., Haapio, M., Groop, P., Grönhagen‐Riska, C., & Finne, P. (2014) · Blood Purification · doi:10.1159/000362861 · Cited by 2
Self-citation
Metadata
- Authors
- Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., & Forsblom, C.
- Affiliations
- Helsinki University Hospital (FI)
- Baker Heart and Diabetes Institute (AU)
- Department of Intensive Care Medicine, The Queen Elizabeth Hospital, Woodville, South Australia, Australia;
- Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland;
- Corresponding author
- Groop, Per-Henrik
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-04-28
- Volume
- 58
- Issue
- 7
- Pages
- 1651-1658
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2699848
- OpenAlex
- W2101457616
- Semantic Scholar
- 8c94474962d440b785728afdfb3a4ed830eedf9d
- Cited by
- 638
- References
- 49
- Citations by year
- 2026: 14 · 2025: 29 · 2024: 30 · 2023: 38 · 2022: 59 · 2021: 43 · 2020: 40 · 2019: 48 · 2018: 55 · 2017: 43 · 2016: 40 · 2015: 41 · 2014: 54 · 2013: 40 · 2012: 23
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Funders
- Wilhelm och Else Stockmanns Stiftelse
- European Commission
- Signe ja Ane Gyllenbergin Säätiö
- Waldemar von Frenckells Stiftelse
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 1 diabetes, chronic kidney disease, all-cause mortality, diabetic nephropathy, albuminuria, microalbuminuria, macroalbuminuria, end-stage renal disease, glomerular filtration rate, hyperfiltration, standardized mortality ratio
- MeSH terms
- Adolescent, Adult, Cause of Death, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Female, Finland, Follow-Up Studies, Glomerular Filtration Rate, Humans, Insulin, Male, Middle Aged, Severity of Illness Index, Cohort Studies, Age of Onset, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.